(Q45759430)

15 December 2017

title

Motor fluctuations and Helicobacter pylori in Parkinson's disease (English)

1 reference

15 December 2017

1 reference

Dag Nyholm

3

0 references

author name string

Karl-Erik Rahne

series ordinal

1

1 reference

15 December 2017

Carl Tagesson

series ordinal

2

1 reference

15 December 2017

publication date

4 September 2013

1 reference

15 December 2017

published in

Journal of Neurology

1 reference

15 December 2017

volume

260

1 reference

15 December 2017

issue

12

1 reference

15 December 2017

page(s)

2974-2980

1 reference

15 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-013-7089-6

exact match

0 references

cites work

Levodopa for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Irregular gastrointestinal drug absorption in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Microbial endocrinology as a basis for improved L-DOPA bioavailability in Parkinson's patients treated for Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Helicobacter pylori: epidemiology and routes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Pathogenesis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Epidemiology of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970s and the 1990s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Helicobacter pylori eradication for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Levodopa and the progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

A rapid-release 50-mg tablet-based 13C-urea breath test for the diagnosis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Early events in proton pump inhibitor-associated exacerbation of corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Influence of anti-ulcer drugs used in Japan on the result of 13 C-urea breath test for the diagnosis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Systematic review: Helicobacter pylori infection and impaired drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-013-7089-6

Pathological consequences of Helicobacter pylori infection

21 January 2018

1 reference

12 December 2020

The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration

1 reference

12 December 2020

Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis.

1 reference

12 December 2020

Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations

1 reference

12 December 2020

Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.

1 reference

12 December 2020

Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group

1 reference

12 December 2020

Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints

1 reference

12 December 2020

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

1 reference

12 December 2020

Helicobacter pylori: ulcers and more: the beginning of an era.

1 reference

12 December 2020

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

12 December 2020

The prevalence of Helicobacter pylori infection in different countries.

1 reference

12 December 2020

In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?

1 reference

12 December 2020

The sensitivity and specificity of the 9-item Wearing-off Questionnaire

1 reference

12 December 2020

Epidemiology of Helicobacter pylori infection

1 reference

12 December 2020

Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists

1 reference

12 December 2020

Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.

1 reference

12 December 2020

10.1007/S00415-013-7089-6

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017